1. Home
  2. TECX vs SNDL Comparison

TECX vs SNDL Comparison

Compare TECX & SNDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

HOLD

Current Price

$19.68

Market Cap

359.0M

Sector

N/A

ML Signal

HOLD

Logo SNDL Inc.

SNDL

SNDL Inc.

HOLD

Current Price

$1.94

Market Cap

432.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TECX
SNDL
Founded
2019
2006
Country
United States
Canada
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
359.0M
432.6M
IPO Year
2018
2019

Fundamental Metrics

Financial Performance
Metric
TECX
SNDL
Price
$19.68
$1.94
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
1
Target Price
$81.20
$5.00
AVG Volume (30 Days)
343.2K
4.2M
Earning Date
11-06-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$683,170,243.00
Revenue This Year
N/A
$5.48
Revenue Next Year
N/A
$3.10
P/E Ratio
N/A
N/A
Revenue Growth
N/A
4.43
52 Week Low
$13.70
$1.15
52 Week High
$61.07
$2.89

Technical Indicators

Market Signals
Indicator
TECX
SNDL
Relative Strength Index (RSI) 53.48 51.40
Support Level $17.79 $1.87
Resistance Level $19.12 $2.34
Average True Range (ATR) 1.42 0.15
MACD -0.20 0.04
Stochastic Oscillator 55.39 39.42

Price Performance

Historical Comparison
TECX
SNDL

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About SNDL SNDL Inc.

SNDL Inc is a private-sector liquor and cannabis retailer in Canada with retail banners that include Ace Liquor, Wine and Beyond, Liquor Depot, Value Buds, and Spiritleaf. The principal activities of the company are the retailing of wines, beers, and spirits. It comprised four reportable segments: liquor retail, cannabis retail, cannabis operations, and investments. Liquor retail includes the sale of wines, beers, and spirits through owned liquor stores. The company generates maximum revenue from liquor retail.

Share on Social Networks: